Drawing for OAN OSTEOPOROSIS ACTION NETWORK

USPTO serial 99879178

OAN OSTEOPOROSIS ACTION NETWORK

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
KEY,THOMAS S
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OAN OSTEOPOROSIS ACTION NETWORK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth K. Rucki

Elizabeth K. Rucki Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799United States

Goods and services

ClassDescriptionStatusFirst use
035Promoting public awareness of osteoporosis, management of osteoporosis and fracture risk reductionACTIVE—
044Providing medical information; Providing health information; Providing health information in the field of osteoporosis and fracture risk reduction, and management of osteoporosis careACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 29, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 29, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Oct 29, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 29, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 28, 2026DOCKASSIGNED TO EXAMINER—
Oct 27, 2026MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 11, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance